Biotelemetry Inc (BEAT) 18.82 $BEAT BioTelemetr
Post# of 273257
Posted On: 09/03/2016 3:21:23 PM
Biotelemetry Inc (BEAT) 18.82 $BEAT
BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)
BioTelemetry, Inc. announces CE mark approval of Holter analysis software
GlobeNewswire - Mon Aug 29, 9:14AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Company has received CE mark approval of its Holter analysis software. The software can be used either on a stand-alone basis or in combination with the Company's family of digital Holter recorders.
BEAT: 18.82 (+0.12)
Look for Shares of CardioNet to Potentially Rebound after Yesterday's 3.87% Sell Off
Comtex SmarTrend(R) - Thu Aug 25, 2:32PM CDT
CardioNet (NASDAQ:BEAT) traded in a range yesterday that spanned from a low of $19.01 to a high of $19.74. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $19.72 on volume of 349,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BEAT: 18.82 (+0.12)
BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)
BioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market
GlobeNewswire - Tue Aug 23, 7:15AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has entered into a strategic partnership with Bloom Technologies, Inc. ("Bloomlife"
, an early stage digital health company. Under the terms of the agreement, Bloomlife will pay BioTelemetry a percentage of revenue to license their proprietary telemetry technology to commercialize a consumer oriented prenatal health sensor. This sensor will collect and deliver a wide variety of prenatal data to expectant mothers that can be shared with their healthcare providers.
BEAT: 18.82 (+0.12)
BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:14AM CDT
Share price of BioTelemetry rallied to a new 52-week high of $21.42 on Aug 18.
BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)
Why BioTelemetry (BEAT) Could Be Positioned for a Surge?
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:16AM CDT
BioTelemetry (BEAT) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
BEAT: 18.82 (+0.12)
New Strong Buy Stocks for August 11th
Tirthankar Chakraborty - Zacks Investment Research - Thu Aug 11, 6:17AM CDT
New Strong Buy Stocks for August 11th
DSCI: 4.72 (-0.12), DISCK: 25.08 (+0.13), DGI: 27.08 (+0.52), BEAT: 18.82 (+0.12), CVCY: 15.78 (+0.31)
Healthways (HWAY) Q2 Earnings Shine, Revenues Miss Mark
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 9:05AM CDT
Healthways reported second-quarter 2016 earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a stellar 53 cents.
HYH: 36.57 (+0.32), BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), HWAY: 24.96 (+0.10)
The Zacks Analyst Blog Highlights: Omega Protein, Central Garden & Pet, BioTelemetry, Trinseo SA and Heritage-Crystal Clean
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:30AM CDT
The Zacks Analyst Blog Highlights: Omega Protein, Central Garden & Pet, BioTelemetry, Trinseo SA and Heritage-Crystal Clean
TSE: 58.51 (+0.92), OME: 25.72 (+0.56), CENT: 25.85 (+0.17), BEAT: 18.82 (+0.12), HCCI: 13.16 (-0.19)
Best 5 Stocks with Sturdy Earnings Growth
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:43AM CDT
Earnings growth more often than not leads to an increase in the share price.
TSE: 58.51 (+0.92), OME: 25.72 (+0.56), CENT: 25.85 (+0.17), BEAT: 18.82 (+0.12), HCCI: 13.16 (-0.19)
Is BioTelemetry (BEAT) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:41AM CDT
BioTelemetry (BEAT) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
BEAT: 18.82 (+0.12)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), BEAT: 18.82 (+0.12)
BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 02, 3:06PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2016.
BEAT: 18.82 (+0.12)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 18.82 (+0.12)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 35.79 (+0.90), HQY: 33.55 (+1.05), BEAT: 18.82 (+0.12), AHS: 36.25 (+0.57)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.91 (+0.48), AG: 12.37 (+0.58), BEAT: 18.82 (+0.12), BGSF: 17.58 (+0.12), ORRF: 21.46 (+0.71)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 18.82 (+0.12)
BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)
BioTelemetry, Inc. announces CE mark approval of Holter analysis software
GlobeNewswire - Mon Aug 29, 9:14AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Company has received CE mark approval of its Holter analysis software. The software can be used either on a stand-alone basis or in combination with the Company's family of digital Holter recorders.
BEAT: 18.82 (+0.12)
Look for Shares of CardioNet to Potentially Rebound after Yesterday's 3.87% Sell Off
Comtex SmarTrend(R) - Thu Aug 25, 2:32PM CDT
CardioNet (NASDAQ:BEAT) traded in a range yesterday that spanned from a low of $19.01 to a high of $19.74. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $19.72 on volume of 349,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BEAT: 18.82 (+0.12)
BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)
BioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom Technologies, Inc. for Use in Prenatal Market
GlobeNewswire - Tue Aug 23, 7:15AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has entered into a strategic partnership with Bloom Technologies, Inc. ("Bloomlife"
, an early stage digital health company. Under the terms of the agreement, Bloomlife will pay BioTelemetry a percentage of revenue to license their proprietary telemetry technology to commercialize a consumer oriented prenatal health sensor. This sensor will collect and deliver a wide variety of prenatal data to expectant mothers that can be shared with their healthcare providers. BEAT: 18.82 (+0.12)
BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:14AM CDT
Share price of BioTelemetry rallied to a new 52-week high of $21.42 on Aug 18.
BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)
Why BioTelemetry (BEAT) Could Be Positioned for a Surge?
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:16AM CDT
BioTelemetry (BEAT) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
BEAT: 18.82 (+0.12)
New Strong Buy Stocks for August 11th
Tirthankar Chakraborty - Zacks Investment Research - Thu Aug 11, 6:17AM CDT
New Strong Buy Stocks for August 11th
DSCI: 4.72 (-0.12), DISCK: 25.08 (+0.13), DGI: 27.08 (+0.52), BEAT: 18.82 (+0.12), CVCY: 15.78 (+0.31)
Healthways (HWAY) Q2 Earnings Shine, Revenues Miss Mark
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 9:05AM CDT
Healthways reported second-quarter 2016 earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a stellar 53 cents.
HYH: 36.57 (+0.32), BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), HWAY: 24.96 (+0.10)
The Zacks Analyst Blog Highlights: Omega Protein, Central Garden & Pet, BioTelemetry, Trinseo SA and Heritage-Crystal Clean
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:30AM CDT
The Zacks Analyst Blog Highlights: Omega Protein, Central Garden & Pet, BioTelemetry, Trinseo SA and Heritage-Crystal Clean
TSE: 58.51 (+0.92), OME: 25.72 (+0.56), CENT: 25.85 (+0.17), BEAT: 18.82 (+0.12), HCCI: 13.16 (-0.19)
Best 5 Stocks with Sturdy Earnings Growth
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:43AM CDT
Earnings growth more often than not leads to an increase in the share price.
TSE: 58.51 (+0.92), OME: 25.72 (+0.56), CENT: 25.85 (+0.17), BEAT: 18.82 (+0.12), HCCI: 13.16 (-0.19)
Is BioTelemetry (BEAT) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:41AM CDT
BioTelemetry (BEAT) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective
BEAT: 18.82 (+0.12)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), HSKA: 52.49 (-0.27), BEAT: 18.82 (+0.12)
BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 02, 3:06PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2016.
BEAT: 18.82 (+0.12)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 18.82 (+0.12)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 35.79 (+0.90), HQY: 33.55 (+1.05), BEAT: 18.82 (+0.12), AHS: 36.25 (+0.57)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 13.91 (+0.48), AG: 12.37 (+0.58), BEAT: 18.82 (+0.12), BGSF: 17.58 (+0.12), ORRF: 21.46 (+0.71)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 18.82 (+0.12)
(0)
(0)Scroll down for more posts ▼